Ace Report Cover
Rivaroxaban is an adequate treatment for thromboprophylaxis after total knee arthroplasty
Reprints
Cite This
Reprints
Cite This
AceReport Image
Arthroplasty
Rivaroxaban is an adequate treatment for thromboprophylaxis after total knee arthroplasty
Verified
This report has been verified by one or more authors of the original publication.
Lancet. 2009 May 16;373(9676):1673-80. Epub 2009 May 4

3148 patients who underwent total knee arthroplasty (TKA) were randomized to thromboprophylaxis using either orally administer rivaroxaban or subcutaneous injection of enoxaparin. This study assessed the efficacy of thromboprophylaxis treatment with rivaroxaban and assessed its non-inferiority to enoxaparin. The results of this study indicated that rivaroxaban was superior in comparison to enoxaparin for the use in patients undergoing total knee arthroplasty.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Rivaroxaban is an adequate treatment for thromboprophylaxis after total knee arthroplasty. ACE Report. 2013;3(5):83. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report